Xvivo Perfusion AB (0RKL) Revenue

0 Followers

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had a revenue of 238.99M in the quarter ending Jun 30, 2026, with -0.82%. This bring the company's revenue in the last twelve months to 895.23M, Decreased 7.27%. In the fiscal year ending Dec 31, 2025, Xvivo Perfusion AB had annual revenue of 812.16M with -1.25% growth.

Revenue (ttm)

895.23M

Revenue Growth

8.79%

P/S Ratio

8.28

Revenue/Employee

kr4,122,665

Employees

197

Market Cap

kr6.73B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	812.16M	-10.25M	-1.25%
Dec 31, 2024	822.41M	224.87M	+37.63%
Dec 31, 2023	597.54M	182.25M	+43.88%
Dec 31, 2022	415.29M	156.91M	+60.73%
Dec 31, 2021	258.39M	78.53M	+43.66%
Dec 31, 2020	179.86M	-40.98M	-18.56%
Dec 31, 2019	220.84M	32.97M	+17.55%
Dec 31, 2018	187.87M	39.53M	+26.65%
Dec 31, 2017	148.34M	―	―